Deepak Parajuli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Deepak Parajuli has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Pisut Koomsap
Asian Institute of Technology
2 shared publications Alok A. Parkhi
Industrial and Manufacturing Engineering, School of Engineering and Technology, Asian Institute of Technology, Pathumthani, Thailand
1 shared publication- Eszter Bodnár
Department of Chemical Engineering, Universitat Rovira i Virgili, E-43007 Tarragona, Spain
1 shared publication - Joan Rosell-Llompart
Department of Chemical Engineering Universitat Rovira I Virgili Tarragona Spain
1 shared publication Komgrit Eawsakul
Department of Applied Thai Traditional Medicine, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand
1 shared publicationNattarat Wongsuwan
Department of Biomedical Engineering, Faculty of Engineering, Mahidol University, Nakhon Pathom 73170, Thailand
1 shared publication
Latest Publications
- Open Access
- 14 July 2026
- Published by Elsevier in Journal of Electrostatics
- Vol. 142
Formation and structuring of hydrophobic nano-coatings via electrospraying
- 14 July 2026
- Published by Elsevier in Journal of Electrostatics
- Vol. 142
Open AccessFormation and structuring of hydrophobic nano-coatings via electrospraying
- Open Access
- 30 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1387
Emerging Nanomedicine Strategies for Chronic Disease Management Based on Chitosan
Chronic diseases such as cancer, cardiovascular disorders, neurodegenerative conditions, chronic respiratory diseases, autoimmune disorders, chronic kidney disease, persistent infectious diseases, diabetes, and ocular inflammation remain leading causes of morbidity and mortality worldwide. Their complex pathophysiologies and the limitations of conventional therapies underscore the urgent need for advanced drug delivery platforms that enhance therapeutic efficacy while minimizing off-target effects and systemic toxicity leading to adverse reactions. Nanomedicine has emerged as a transformative approach, with chitosan-based nanocarriers offering advantages due to their biocompatibility, biodegradability, mucoadhesive properties, and ability to be physic-chemically modified. These nanocarriers improve solubility, stability, bioavailability, and the therapeutic index of drugs, while enabling controlled release, targeted delivery, and immune modulation. This review highlights recent advances in chitosan-based nanomedicine for the management of chronic disease. We discuss methods of synthesis such as ionic gelation and electrospray, functionalization approaches, and immunomodulatory roles that expand therapeutic potential. The evidence emphasizes that chitosan nanocarriers are a versatile, safe, and effective platform which can be used to improve clinical results, reduce adverse effects, and advance the science of personalized medicine.
- 30 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1387
Open AccessEmerging Nanomedicine Strategies for Chronic Disease Management Based on Chitosan
Chronic diseases such as cancer, cardiovascular disorders, neurodegenerative conditions, chronic respiratory diseases, autoimmune disorders, chronic kidney disease, persistent infectious diseases, diabetes, and ocular inflammation remain leading causes of morbidity and mortality worldwide. Their complex pathophysiologies and the limitations of conventional therapies underscore the urgent need for advanced drug delivery platforms that enhance therapeutic efficacy while minimizing off-target effects and systemic toxicity leading to adverse reactions. Nanomedicine has emerged as a transformative approach, with chitosan-based nanocarriers offering advantages due to their biocompatibility, biodegradability, mucoadhesive properties, and ability to be physic-chemically modified. These nanocarriers improve solubility, stability, bioavailability, and the therapeutic index of drugs, while enabling controlled release, targeted delivery, and immune modulation. This review highlights recent advances in chitosan-based nanomedicine for the management of chronic disease. We discuss methods of synthesis such as ionic gelation and electrospray, functionalization approaches, and immunomodulatory roles that expand therapeutic potential. The evidence emphasizes that chitosan nanocarriers are a versatile, safe, and effective platform which can be used to improve clinical results, reduce adverse effects, and advance the science of personalized medicine.
- 22 February 2023
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 248 (6) , 481-491
Antibiotic impregnation and nanocoating of external ventricular drainage catheters for antibacterial applications: Evaluation of in vitro studies and molecular docking
The most suitable method to treat hydrocephalus disease is to insert a shunt catheter that drains the cerebral spinal fluid (CSF); however, shunt implantation is often associated with various bacterial infections. In this study, antibiotic-loaded nanospheres were prepared using the solvent evaporation technique and coated on an antibiotic-impregnated shunt surface to promote shunt antibacterial properties. Clindamycin (CDM) and rifampicin (RIF) were in combination loaded in a single nanosphere, whereas trimethoprim (TMP) was loaded individually in triblock copolymers [(d,l-lactide-random-ε-caprolactone)-block-poly(ethylene glycol)-block-(d,l-lactide-random-ε-caprolactone)] (PLEC). The drug-loading content, encapsulation efficiency, yield, size, and zeta potential of the antibiotic-loaded nanospheres were measured. The results showed that the drug-loading content of clindamycin- and rifampicin-loaded nanospheres (CDM/RIF-NPs) was approximately 3% and 8%, respectively, at a drug to polymer ratio of 1:2. In addition, trimethoprim-loaded nanospheres (TMP-NPs) showed nearly 7% drug loading at equal drug and polymer ratios. The amount of drug release was determined before and after the coating of nanospheres on the shunt surface. In addition, in silico molecular docking studies indicated the good chemical interaction of these antibiotics with PLEC, and the results were consistent with those of impregnation studies. Antibacterial tests of coated external ventricular drainage showed antibacterial activity for up to 21 days.
- 22 February 2023
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 248 (6) , 481-491
Antibiotic impregnation and nanocoating of external ventricular drainage catheters for antibacterial applications: Evaluation of in vitro studies and molecular docking
The most suitable method to treat hydrocephalus disease is to insert a shunt catheter that drains the cerebral spinal fluid (CSF); however, shunt implantation is often associated with various bacterial infections. In this study, antibiotic-loaded nanospheres were prepared using the solvent evaporation technique and coated on an antibiotic-impregnated shunt surface to promote shunt antibacterial properties. Clindamycin (CDM) and rifampicin (RIF) were in combination loaded in a single nanosphere, whereas trimethoprim (TMP) was loaded individually in triblock copolymers [(d,l-lactide-random-ε-caprolactone)-block-poly(ethylene glycol)-block-(d,l-lactide-random-ε-caprolactone)] (PLEC). The drug-loading content, encapsulation efficiency, yield, size, and zeta potential of the antibiotic-loaded nanospheres were measured. The results showed that the drug-loading content of clindamycin- and rifampicin-loaded nanospheres (CDM/RIF-NPs) was approximately 3% and 8%, respectively, at a drug to polymer ratio of 1:2. In addition, trimethoprim-loaded nanospheres (TMP-NPs) showed nearly 7% drug loading at equal drug and polymer ratios. The amount of drug release was determined before and after the coating of nanospheres on the shunt surface. In addition, in silico molecular docking studies indicated the good chemical interaction of these antibiotics with PLEC, and the results were consistent with those of impregnation studies. Antibacterial tests of coated external ventricular drainage showed antibacterial activity for up to 21 days.
- 20 March 2021
- Published by Springer Nature in Bulletin of Materials Science
- Vol. 44 (1) , 1-12
Influence of solvents on a near-field electrospun straight fine fibre
- 20 March 2021
- Published by Springer Nature in Bulletin of Materials Science
- Vol. 44 (1) , 1-12
Influence of solvents on a near-field electrospun straight fine fibre
- 2 July 2016
- Published by Taylor & Francis in Virtual and Physical Prototyping
- Vol. 11 (3) , 193-207
Experimental investigation on process parameters of near-field deposition of electrospinning-based rapid prototyping
Near-field electrospinning (NFES) with its capability to produce a straight fine fibre has been integrated into additive manufacturing for the fabrication of scaffolds with controllable pattern structures. However, building the third dimension with NFES is not easy due to the unsolidified fibre while being deposited. Presented in this paper is an investigation on the influence of process parameters on achieving a small cylindrical fibre from the near-field fibre deposition of an electrospinning-based rapid prototyping. A set of experiments have been conducted on solutions of polycaprolactone (PCL) in N,N-dimethylformamide (DMF). Parameters of interest are voltage, standoff distance, polymer concentration, environmental condition and needle size. From the experimental results, polymer concentration, environmental condition and needle size had influence on achieving a small cylindrical fibre. Under near-field deposition, the concentration should be high, the needle should be small and the temperature should be maintained during the process.
- 2 July 2016
- Published by Taylor & Francis in Virtual and Physical Prototyping
- Vol. 11 (3) , 193-207
Experimental investigation on process parameters of near-field deposition of electrospinning-based rapid prototyping
Near-field electrospinning (NFES) with its capability to produce a straight fine fibre has been integrated into additive manufacturing for the fabrication of scaffolds with controllable pattern structures. However, building the third dimension with NFES is not easy due to the unsolidified fibre while being deposited. Presented in this paper is an investigation on the influence of process parameters on achieving a small cylindrical fibre from the near-field fibre deposition of an electrospinning-based rapid prototyping. A set of experiments have been conducted on solutions of polycaprolactone (PCL) in N,N-dimethylformamide (DMF). Parameters of interest are voltage, standoff distance, polymer concentration, environmental condition and needle size. From the experimental results, polymer concentration, environmental condition and needle size had influence on achieving a small cylindrical fibre. Under near-field deposition, the concentration should be high, the needle should be small and the temperature should be maintained during the process.